查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771714

美國心血管設備市場規模、佔有率、趨勢分析報告：按產品、最終用途和細分市場預測，2025 年至 2033 年

U.S. Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring, Surgical Devices), By End-use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國心血管設備市場概況

美國心血管設備市場規模預計在 2024 年為 223.9 億美元，預計到 2033 年將達到 376.6 億美元，2025 年至 2033 年的複合年成長率為 5.8%。心血管設備是專門用於診斷或治療心臟或血管疾病的醫療設備，包括心律調節器、支架、人工瓣膜、心臟去顫器、血管成形術設備和心導管等設備。

心血管疾病盛行率的上升是推動市場成長的因素之一。根據美國心臟協會 (AHA) 的數據，2024 年 1 月美國因心血管疾病死亡的人數將達到 931,578 人，比前一年增加近 3,000 人。此外，年齡調整後的心血管疾病死亡率將達到每 10 萬人 233.3 人，比前一年增加 4.0%。死亡率的上升趨勢凸顯了心血管疾病帶來的持續挑戰，並凸顯了對創新心血管設備和干涉措施的迫切需求。

此外，根據美國心臟協會 (AHA) 2024 年 6 月發布的報告，到 2050 年，心血管疾病 (CVD) 可能影響超過 1.84 億美國人，佔總人口的 61% 以上。隨著盛行率的上升，CVD 相關的醫療保健費用預計將大幅上升，並可能達到 1.8 兆美元。病例數和相關費用的上升凸顯了心血管設備發展亟需的緊迫性。因此，隨著對支持早期診斷、預防保健和有效治療方案的創新技術的需求日益成長，以應對 CVD 對公眾健康的廣泛影響，美國心血管設備市場預計將經歷顯著成長。

日益增多的宣傳活動和政府主導的心血管疾病早期發現篩檢計畫使更多患者能夠及時接受診斷和治療，從而促進了市場的擴張。根據美國心臟協會 (AHA)、美國心臟病學會 (ACC)、美國胸腔科醫師學會 (ACCP) 和心律學會 (HRS) 於 2023 年 11 月發布的 2023 年心房顫動診斷和管理指南，強調了意識提升和實施定期篩檢的重要性，尤其是對於老年人等高風險族群。這些指南提倡定期進行脈搏和心電圖篩檢，以確保早期發現和有效管理心血管疾病。例如，早期發現和治療心房顫動至關重要，因為它可以顯著降低中風和其他嚴重併發症的風險。

針對心血管疾病 (CVD) 的篩檢計畫效率將推動市場成長。根據施普林格·自然 (Springer Nature) 報道，2024 年 6 月，一項心臟病學報告綜述將檢驗篩檢計畫的影響。這篇綜述將重點介紹 STROKESTOP 和 AF-SCREEN 等多中心研究的結果，這些研究表明，有針對性的篩檢可顯著提高心血管疾病 (CVD) 的檢出率，尤其是在老年人群中。這篇綜述強烈支持建立全國篩檢舉措，以應對與心房顫動相關的併發症日益加重的負擔，並強調早期發現和介入的關鍵作用。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國心血管設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國心血管設備市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章美國心血管設備市場：按產品分類的估計和趨勢分析

  • 美國心血管設備市場：產品儀表板
  • 美國心血管設備市場：產品差異分析
  • 美國心血管設備市場規模、預測與趨勢分析（按產品，2021-2033 年）
  • 診斷和監控
    • 心電圖
    • 植入式心臟監測儀
    • 心電圖監測
    • 移動心電遙測
    • MRI
    • 心血管超音波
    • 心臟診斷導管插入術
    • PET掃描儀
  • 手術設備
    • 心臟再同步治療（CRT）
    • 植入式心臟整流去顫器（ICD）
    • 心律調節器
    • 冠狀動脈支架
    • 導管
    • 導管導引線
    • 套管
    • 閥門
    • 阻塞設備

第5章美國心血管設備市場：最終用途、估計與趨勢分析

  • 美國心血管設備市場：最終用戶儀表板
  • 美國心血管設備市場：最終用途差異分析
  • 美國心血管設備市場規模、預測和趨勢分析（按最終用途，2021-2033 年）
  • 醫院
  • 門診手術中心
  • 診斷中心
  • 其他

第6章 競爭態勢

  • 主要製造商的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 2024年主要企業市場佔有率分析
    • Abbott
    • GE HealthCare
    • Edwards Lifesciences Corporation
    • Siemens Healthineers AG
    • Canon Medical Systems
    • B. Braun SE
    • LivaNova, Inc.
    • Cardinal Health
    • Medtronic
    • Boston Scientific Corporation
    • WL Gore & Associates, Inc.
    • BIOTRONIK SE & Co. KG
Product Code: GVR-4-68040-631-2

U.S. Cardiovascular Devices Market Summary

The U.S. cardiovascular devices market size was estimated at USD 22.39 billion in 2024 and is projected to reach USD 37.66 billion by 2033, growing at a CAGR of 5.8% from 2025 to 2033. A cardiovascular device is a medical tool explicitly used to diagnose or treat diseases of the heart and blood vessels, including instruments like pacemakers, stents, artificial valves, defibrillators, angioplasty tools, and cardiac catheters.

The rising incidence of cardiovascular diseases is one of the factors boosting market growth. According to the America Heart Association (AHA), in January 2024, there were 931,578 deaths in the U.S. attributed to cardiovascular disease, marking an increase of nearly 3,000 compared to the previous year. Additionally, the age-adjusted death rate from cardiovascular conditions rose to 233.3 per 100,000 individuals, reflecting a 4.0% increase from the prior year. This upward trend in mortality rates emphasizes the ongoing challenges posed by cardiovascular diseases, highlighting the critical need for innovative cardiovascular devices and interventions.

Moreover, as per the American Heart Association (AHA) article published in June 2024, cardiovascular disease (CVD) could affect over 184 million Americans, more than 61% of the population, by 2050. Alongside this expected rise in prevalence, CVD-related healthcare costs are expected to escalate dramatically, potentially reaching USD 1.8 trillion. This forecasted growth in cases and associated costs highlights an urgent need for advancements in cardiovascular devices. Therefore, the U.S. cardiovascular devices market is positioned for substantial growth as demand intensifies for innovative technologies that support early diagnosis, preventive care, and effective treatment solutions to manage the widespread impact of CVD on public health.

Increasing awareness campaigns and government-initiated screening programs for early detection of CVDs contribute to market expansion by ensuring more patients receive timely diagnosis and treatment. According to the American Heart Association, Inc. article published in November 2023, the 2023 guidelines from the American Heart Association (AHA), American College of Cardiology (ACC), American College of Chest Physicians (ACCP), and the Heart Rhythm Society (HRS) for the diagnosis & management of AFib stress the importance of raising awareness and implementing routine screening, especially in high-risk groups like older adults. These guidelines advocate for regular pulse and ECG screenings to ensure early detection and effective management of CVDs. For instance, early identification and treatment of AFib are crucial as they can significantly lower the risk of stroke and other serious complications.

The efficiency of targeted screening programs for CVDs fuels market growth. According to Springer Nature, in June 2024, a review of cardiology reports will examine the impact of screening programs. It highlights findings from multicenter studies, such as STROKESTOP and AF-SCREEN, which show that targeted screening greatly enhances the detection of CVDs, especially among older adults. The review strongly supports establishing national screening initiatives to address the growing burden of AFib-related complications, highlighting the critical role of early detection and intervention.

U.S. Cardiovascular Devices Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. cardiovascular devices market report based on product, and end-use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostic & Monitoring
    • ECG
    • Implantable Cardiac Monitors
    • Holter Monitors
    • Mobile Cardiac Telemetry
    • MRI
    • Cardiovascular Ultrasound
    • Cardiac Diagnostic Catheters
    • PET Scanner
  • Surgical Devices
    • Cardiac Resynchronization Therapy (CRT)
    • Implantable Cardioverter Defibrillators (ICDs)
    • Pacemakers
    • Coronary Stents
    • Catheters
    • Guidewires
    • Cannula
    • Valves
    • Occlusion Devices
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. End Use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Cardiovascular Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiovascular diseases (CVDs)
      • 3.2.1.2. Increasing awareness and screening programs
      • 3.2.1.3. Technological advancement in CVDs devices
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs associated with the devices
      • 3.2.2.2. Product Recalls
  • 3.3. U.S. Cardiovascular Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Cardiovascular Devices Market: Product Estimates & Trend Analysis

  • 4.1. U.S. Cardiovascular Devices Market: Product Dashboard
  • 4.2. U.S. Cardiovascular Devices Market: Product Movement Analysis
  • 4.3. U.S. Cardiovascular Devices Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Diagnostic & Monitoring
    • 4.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.2. ECG
      • 4.4.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.3. Implantable Cardiac Monitors
      • 4.4.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.4. Holter Monitors
      • 4.4.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.5. Mobile Cardiac Telemetry
      • 4.4.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.6. MRI
      • 4.4.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.7. Cardiovascular Ultrasound
      • 4.4.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.8. Cardiac Diagnostic Catheters
      • 4.4.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.9. PET Scanner
      • 4.4.9.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 4.5. Surgical Devices
    • 4.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.2. Cardiac Resynchronization Therapy (CRT)
      • 4.5.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.3. Implantable Cardioverter Defibrillators (ICDs)
      • 4.5.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.4. Pacemakers
      • 4.5.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.5. Coronary Stents
      • 4.5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.6. Catheters
      • 4.5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.7. Guidewires
      • 4.5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.8. Cannula
      • 4.5.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.9. Valves
      • 4.5.9.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.10. Occlusion Devices
      • 4.5.10.1. Market estimates and forecast 2021 - 2033 (USD Million)

Chapter 5. U.S. Cardiovascular Devices Market: End Use Estimates & Trend Analysis

  • 5.1. U.S. Cardiovascular Devices Market: End Use Dashboard
  • 5.2. U.S. Cardiovascular Devices Market: End Use Movement Analysis
  • 5.3. U.S. Cardiovascular Devices Market Size & Forecasts and Trend Analysis, by End Use , 2021-2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 5.5. Ambulatory Surgical Centers
    • 5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 5.6. Diagnostic Centers
    • 5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2024
    • 6.3.4. Abbott
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. GE HealthCare
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Edwards Lifesciences Corporation
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Siemens Healthineers AG
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Canon Medical Systems
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. B. Braun SE
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. LivaNova, Inc.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Cardinal Health
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Medtronic
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Boston Scientific Corporation
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. W. L. Gore & Associates, Inc.
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. BIOTRONIK SE & Co. KG
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Product benchmarking
      • 6.3.15.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 4. U.S. cardiovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 5. Key companies undergoing expansions
  • Table 6. Key companies undergoing acquisitions
  • Table 7. Key companies undergoing collaborations
  • Table 8. Key companies launching new products
  • Table 9. Key companies undergoing partnerships
  • Table 10. Key companies undertaking other strategies

List of Figures

  • Fig. 1 U.S. cardiovascular devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 U.S. cardiovascular devices market revenues, 2024, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 U.S. cardiovascular devices market: Product outlook:
  • Fig. 14 U.S. cardiovascular devices market: Product movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Diagnostic and monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 ECG market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Implantable cardiac monitors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Holter monitors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Mobile cardiac telemetry market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 MRI market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Cardiovascular ultrasound market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Cardiac diagnostic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Pet scan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 MRI market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Pacemakers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Coronary stents market estimates and forecasts, 2021 - 2033 (USD Million
  • Fig. 30 Catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Valves market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Occlusion devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. cardiovascular devices market: End use outlook:
  • Fig. 36 U.S. cardiovascular devices market: End use movement analysis
  • Fig. 37 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Ambulatory surgical centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Diagnostic centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2021 - 2033 (USD Million)